Patents by Inventor Daohai DU

Daohai DU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases
    Patent number: 11013745
    Abstract: The present invention provides a compound represented by formula I, pharmaceutically acceptable salts, enantiomers, diastereomers or racemates thereof, the preparation method thereof, the pharmaceutical composition comprising the same, and the use thereof in the preparation of a medicament for treating a disease or condition mediated by EED and/or PRC2. The compound of the present invention can be used treating PRC2-mediated diseases or conditions.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: May 25, 2021
    Assignees: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, SUZHOU SUPLEAD LIFE SCIENCES CO., LTD.
    Inventors: Bing Zhou, Cheng Luo, Yaxi Yang, Yuanyuan Zhang, Daohai Du, Hualiang Jiang, Gang Qiao, Xinjun Wang
  • TRIAZOLOPYRIMIDINE, TRIAZOLOPYRIDINE COMPOUNDS, AND THE COMPOSITION THEREOF FOR TREATING PRC2-MEDIATED DISEASES
    Publication number: 20200261459
    Abstract: The present invention provides a compound represented by formula I, pharmaceutically acceptable salts, enantiomers, diastereomers or racemates thereof, the preparation method thereof, the pharmaceutical composition comprising the same, and the use thereof in the preparation of a medicament for treating a disease or condition mediated by EED and/or PRC2. The compound of the present invention can be used treating PRC2-mediated diseases or conditions.
    Type: Application
    Filed: August 29, 2018
    Publication date: August 20, 2020
    Inventors: Bing ZHOU, Cheng LUO, Yaxi YANG, Yuanyuan ZHANG, Daohai DU, Hualiang JIANG, Gang QIAO, Xinjun WANG